...
首页> 外文期刊>The American Surgeon >MRI versus Ultrasonography and Mammography for Preoperative Assessment of Breast Cancer
【24h】

MRI versus Ultrasonography and Mammography for Preoperative Assessment of Breast Cancer

机译:MRI,超声和乳腺X线摄影术对乳腺癌的术前评估

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Mammography and ultrasonography are traditional for preoperative estimation of breast cancer size; magnetic resonance imaging (MRI) is more recent but not as well studied. We compared ultrasonography, mammography, and MRI for preoperative imaging of primary breast cancer presenting as a mass in patients treated at our center over a 2-year period. Of the 61 breast cancers with all three imaging modalities performed, 52 were infiltrating ductal cancer, 5 were infiltrating lobular cancer, 2 were ductal carcinoma in situ, and 2 were other histologic types. When pathologic size was used to determine the accuracy of imaging assessments, the Pearson correlation coefficient was better for MRI (r = 0.80) than ultrasonography (r = 0.57) or mammography (r = 0.26). Mean tumor size was 2.1 cm by mammography, 1.73 cm by ultrasonography, 2.65 cm by MRI, and 2.76 cm by pathology. MRI-based tumor size was within 1 cm of pathologic size in 44 (72%) tumors, > 1 cm above pathologic size in 6 (10%) tumors, and > 1 cm below pathologic size in 11 (18%) tumors. We conclude that MRI is more accurate than either ultrasonography or mammography for assessment of the size of primary breast cancer presenting as a mass. [PUBLICATION ABSTRACT]
机译:乳房X线和超声检查是传统的术前估计乳腺癌大小的方法。磁共振成像(MRI)是最近才开始研究的,但没有得到很好的研究。我们比较了超声检查,乳房X线检查和MRI对原发性乳腺癌的术前影像学表现,结果显示在我们中心治疗了2年以上的患者中,肿块呈肿块状。在完成全部三种成像方式的61例乳腺癌中,有52例为浸润性导管癌,5例为浸润性小叶癌,2例为原位导管癌,另外2例为其他组织学类型。当使用病理学大小确定影像学评估的准确性时,MRI的皮尔逊相关系数(r = 0.80)优于超声检查(r = 0.57)或乳腺摄影(r = 0.26)。乳房X线照相术的平均肿瘤大小为2.1 cm,超声波显像术的平均肿瘤大小为1.73 cm,MRI检查为2.65 cm,病理学检查为2.76 cm。基于MRI的肿瘤大小在44个(72%)肿瘤的病理大小范围内不到1 cm,在6个(10%)的肿瘤的病理大小之上> 1 cm,在11个(18%)的肿瘤的病理大小之下> 1 cm。我们得出结论,对于原发性乳腺癌的肿块评估,MRI比超声检查或乳房X线检查更准确。 [出版物摘要]

著录项

  • 来源
    《The American Surgeon》 |2009年第10期|p.970-975|共6页
  • 作者单位

    NABIL WASIF, M.D., JENNIFER GARREAU, M.D., ALICIA TERANDO, M.D., DANIEL KIRSCH, M.D., DEBRA F. MUND, M.D., ARMANDO E. GIULIANO, M.D.From the John Wayne Cancer Institute at Saint John's Health Center, Santa Monica, CaliforniaPresented at the 20th Annual Scientific Meeting of the Southern California Chapter of the American College of Surgeons in Santa Barbara, CA, January 16-18, 2009.Address correspondence and reprint requests to Armando E. Giuliano, M. D., John Wayne Cancer Institute at Saint John's Health Center, 2200 Santa Monica Boulevard, Santa Monica, CA 90404. E-mail: giulianoa@jwci.org.Supported by funding from the Gonda (Goldschmied) Research Laboratories of the John Wayne Cancer Institute at Saint John's Health Center, QVC and the Fashion Footwear Association of New York Charitable Foundation (New York, NY), the Margie and Robert E. Petersen Foundation (Los Angeles, CA), Mrs. Lois Rosen (Los Angeles, CA), the Associates for Breast and Prostate Cancer Studies (Santa Monica, CA), the Family of Robert Novick (Los Angeles, CA), Ruth and Martin H. Weil Fund (Los Angeles, CA), and the Wrather Family Foundation (Los Alamos, CA).;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号